Wall Street is rapidly selling stocks of companies vulnerable to AI disruption, wiping billions from financial firms such as ...

Ocular Therapeutix's current wet AMD treatment is dominated by anti-VEGF drugs, with EYLEA holding a 63% global market share ...

Q4 2025 Earnings Call February 12, 2026 4:00 AM ESTCompany ParticipantsDavid Knibbe - Chairman of Executive Board & CEOAnnemiek T.

Amtrak is set to unveil its new Airo trains this summer, boasting better accessibility and modern amenities.

According to a global ranking of how transparent a country’s public sector is perceived to be by experts and business ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the fourth quarter and full year ended ...

San Antonio Independent School District leaders on Tuesday unveiled a sweeping plan to shrink the district’s footprint and swap aging buildings for fewer, larger, state-of-the-art campuses. Internally ...

On Wall Street, rising fears about artificial intelligence (AI) keep pummeling the shares of companies at risk of being ...

The two companies and market darling Pro Medicus reset expectations for what it is like to get hammered on results day.

Changing managers in the midst of an ongoing season is not new, of course - it seems to happen more often than not - but the context within which they are seeking to replace Thomas Frank is unusual, ...

Kevin Kelly, founding editor of "Wired" magazine and a lifelong observer of technology in motion, returns to Motley Fool co-founder David Gardner's "Rule Breaker Investing" for a conversation about ...

Gold Spot US Dollar, Silver Spot US Dollar, S&P 500, Dow Jones Industrial Average. Read 's Market Analysis on Investing.com ...